Mergers & Acquisitions, Science, Computers & Technology, Commercial Law & Contracts

Personal Data Transfers from the European Economic Area: Time to Consider Binding Corporate Rules 2.0

by Rafi Azim-Khan, Steven Farmer | Pillsbury Global Sourcing Practice on 5/16/2013

What exactly is the '"best" solution for an international business needing to handle and transfer personal data across borders? This has become an increasingly important and common question as business becomes more...more

China Life Sciences Health Industry Client Briefing – April 2013 (May 15, 2013)

by Vicki Lung, Gordon B. Schatz, Katherine Yang, Amy Yin | Reed Smith on 5/15/2013

Pharmaceuticals, Medical Devices, Health Care & Life Sciences - ..Drugs - Approval of Innovative Drugs and Key Sector Generic Drugs to be Expedited (Shanghai Securities Journal 2013-04-23): Given the...more

Capital Infusion - May 2013: Deal Spotlight: Patton Boggs Advises on Innovative Health Care Transaction

by Adam Connatser, Jon Finger, Rani Hauth Guerra, J. Atwood Jeter, David McLean | Patton Boggs LLP on 5/13/2013

Patton Boggs recently advised Satori Capital, a Dallas-based private equity firm, on its acquisition of Longhorn Health Solutions, Inc. Longhorn is headquartered in Austin, Texas and is a leading direct-to-home provider of...more

Meso Scale Diagnostics, LLC v. Roche Diagnostics GmbH, C.A. No. 5589-VCP (Del. Ch. Feb. 22, 2013) (Parsons, V.C.)

by Potter Anderson & Corroon LLP on 3/6/2013

In this memorandum opinion addressing defendants’ motion for summary judgment, the Court of Chancery dismissed plaintiffs’ claim that a reverse triangular merger constituted an assignment of rights in breach of a contractual...more

How to Ensure That Your Company’s Data Doesn’t Get Lost in the Clouds PART III

by Fuerst Ittleman David & Joseph, PL on 2/6/2013

Cloud computing has become an increasingly popular option for businesses to cheaply and efficiently manage their data systems. Businesses interested in utilizing these services should be cautious, however, when entering into...more

Acquiring IT Assets in M&A May Pose Greater Liability Than Value

by Scott & Scott, LLP on 1/15/2013

Robert J. Scott, Managing Partner of Scott & Scott, LLP, says IT assets acquired in a merger may have greater liability attached to them than the assets are worth. Recent cases including Cincom vs. Novelis and ACS vs. Cincom...more

Business Tort Suit Brings Sanctions

by James V. Irving | Bean, Kinney & Korman, PC on 12/31/2012

Virginia’s business-friendly laws and precedents provide employers with powerful remedies and employees with effective deterrents against wrongful conduct in business affairs. As a Fairfax Circuit judge has recently...more

Winshall v. Viacom Int'l Inc., C.A. No. 6074-CS (Del. Ch. Dec. 12, 2012) (Strine, C.)

by Potter Anderson & Corroon LLP on 12/19/2012

In this memorandum opinion, the Court of Chancery held that stockholders of an acquired video game developer were not required to indemnify the acquirer for losses it incurred defending claims based on intellectual property...more

New FTC/DOJ Position Will Require Heightened Regulatory Reporting of Pharma, Biological and Diagnostic Licenses -- October 25,...

by Loeb & Loeb LLP on 10/3/2012

The Federal Trade Commission and Department of Justice recently announced revisions to the Hart-Scott-Rodino (HSR) Act’s premerger notification rules to require enhanced reporting of transactions (including licenses) relating...more

Impact of the EU Cookie Directive on US Companies

by Carr, McClellan, Ingersoll, Thompson & Horn -... on 10/2/2012

A number of national enforcement agencies recently indicated they are going to start actively enforcing 2009/135/EC Directive (the “EU Cookie Directive”). If a US company has business operations in an EU member country, or...more

FTC Seeks Comments on Proposed HSR Rule Amendments Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical...

by Perkins Coie on 9/10/2012

The Federal Trade Commission (“FTC”) recently announced and asked for comments on proposed changes to the premerger notification rules under the Hart-Scott-Rodino Act (“HSR Act”). The proposed rules would require...more

FTC Sights Set on Pharma Deals – Calls for Additional Hart-Scott-Rodino Reporting

by Proskauer Rose LLP on 8/29/2012

The Federal Trade Commission has proposed expanding Hart-Scott-Rodino reporting and waiting period obligations for certain pharmaceutical, biologics and medicine manufacturing licenses. The new rules are subject to public...more

FTC Flexes Healthcare Regulatory Muscle

by Morgan Lewis on 8/23/2012

Proposed rule includes new requirements for reporting pharmaceutical patent transfers. On August 13, the Federal Trade Commission (FTC) released proposed amendments to the premerger notification rules (the Proposed...more

Yet Another Turn of the Screw: The FTC Again Targets Pharmaceutical Industry, This Time Through the HSR Act

by K&L Gates LLP on 8/21/2012

Fresh from its victory in the Third Circuit on “pay-for-delay” deals involving brand name and generic pharmaceutical companies, the Federal Trade Commission (“FTC”) has announced yet another initiative aimed at the...more

FTC Proposes Amendments to HSR Rules Targeting Certain Pharmaceutical Licensing Arrangements

by Mintz Levin - Antitrust on 8/17/2012

The Federal Trade Commission (FTC) recently announced proposed amendments to the Premerger Notification Rules (HSR Rules) to clarify reporting requirements under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as...more

FTC’s Proposed Rules Would Generate More HSR Filings for Transfers of Pharmaceutical Patent Rights

by McDermott Will & Emery on 8/17/2012

The U.S. Federal Trade Commission’s new proposed Hart-Scott-Rodino Act rules will apply only to transfers of pharmaceutical patent rights and are expected to increase the number of filings. Comments on the proposed rules will...more

FTC Proposes Amendments to the Premerger Notification Rules to Expand the Reportability of Transfers of Exclusive Patent Rights in...

by Sheppard Mullin Richter & Hampton LLP on 8/16/2012

On August 13, 2012, the Federal Trade Commission (“FTC”) proposed amendments to the Premerger Notification Rules issued under the Hart Scott Rodino Antitrust Improvements Act of 1976 (the “HSR Act”). The proposed amendments...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Mergers & Acquisitions › Science, Computers & Technology › Commercial Law & Contracts

Personal Data Transfers from the European Economic Area: Time to Consider Binding Corporate Rules 2.0

China Life Sciences Health Industry Client Briefing – April 2013 (May 15, 2013)

Capital Infusion - May 2013: Deal Spotlight: Patton Boggs Advises on Innovative Health Care Transaction

Meso Scale Diagnostics, LLC v. Roche Diagnostics GmbH, C.A. No. 5589-VCP (Del. Ch. Feb. 22, 2013) (Parsons, V.C.)

How to Ensure That Your Company’s Data Doesn’t Get Lost in the Clouds PART III

Acquiring IT Assets in M&A May Pose Greater Liability Than Value

Business Tort Suit Brings Sanctions

Winshall v. Viacom Int'l Inc., C.A. No. 6074-CS (Del. Ch. Dec. 12, 2012) (Strine, C.)

New FTC/DOJ Position Will Require Heightened Regulatory Reporting of Pharma, Biological and Diagnostic Licenses -- October 25,...

Impact of the EU Cookie Directive on US Companies

FTC Seeks Comments on Proposed HSR Rule Amendments Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical...

FTC Sights Set on Pharma Deals – Calls for Additional Hart-Scott-Rodino Reporting

FTC Flexes Healthcare Regulatory Muscle

Yet Another Turn of the Screw: The FTC Again Targets Pharmaceutical Industry, This Time Through the HSR Act

FTC Proposes Amendments to HSR Rules Targeting Certain Pharmaceutical Licensing Arrangements

FTC’s Proposed Rules Would Generate More HSR Filings for Transfers of Pharmaceutical Patent Rights

FTC Proposes Amendments to the Premerger Notification Rules to Expand the Reportability of Transfers of Exclusive Patent Rights in...

FTC Proposes New HSR Rules for Exclusive Patent Licenses in the Pharmaceutical Industry

FTC Proposes Changes to HSR Reportability of Patent Licenses

FTC May Expand Premerger Reporting Requirements to Include Pharmaceutical Patent Exclusive Marketing and Sales Licenses

Varicent Customers Should Plan for Audits by IBM

China Conditionally Clears Western Digital’s Acquisition of Hitachi’s Hard Disk Drive Business

Congratulations Double Down Interactive

Taiwan Antitrust Newsletter Q1 2012

Gaming Legal News: September 22, 2011 • Volume 4, Number 28

Expand Your Reach